The Wall Street Journal reported Saturday that pharma giants Pfizer and Mylan are nearing a deal that could create a global powerhouse in the low-price drug market. A formal agreement could be announced as soon as Monday, the paper reported, citing unnamed sources familiar with the discussions. Neither Pfizer nor Mylan responded to requests for comment from CNN Business on Saturday.
The first generic competitor to Mylan's EpiPen, the emergency treatment for allergic reactions, gained FDA approval last year. EpiPens were added to the FDA's drug shortage list two years after Mylan increased the price of the product by more than 400%, leading to public outrage.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Won't be low priced for much longer
I'm an old overweight guy. Things like high blood pressure and cholesterol medication are cheap, considering they help prevent massive heart attacks.
Hmmm, with lesser competition, it's easier for big corporations to dictate and control prices. I hope this low-price drug market goal is going to happen.
You went crazy over sprint and t-mobile yesterday but this is a big win ? This proves beyond a shadow of a doubt where your priorities lays. Not a peep out of democrats and you reporting it as a good deal. This is a shame. This is why we have President Trump.
Nonononononononono
South Africa South Africa Latest News, South Africa South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer in talks to merge off-patent drugs business with Mylan: sourcePfizer Inc is in talks to merge its off-patent drugs business with Mylan NV in a... Seriously can we STOP all the mega mergers Mylan was the one that increased the compensation of CEO HeatherBresch (daughter of FakeDem JoeManchin) 600% while jacking up the price of the lifesaving Epipen 400%.
Source: Reuters - 🏆 2. / 97 Read more »
Pfizer in talks to merge off-patent drugs business with MylanPfizer Inc is in talks to merge its off-patent drugs business with Mylan NV in a... Further consolidation that will result in increased drug prices. Republicans will say this is free market principals. Americans will blame Democrats either way.
Source: Reuters - 🏆 2. / 97 Read more »
Pfizer Nears Deal to Combine off-Patent Drug Business With MylanPfizer is in talks to merge its off-patent drugs business with generic drugmaker Mylan, in a deal that would create a giant global seller of lower-priced medicines. Sr. lopez atención sr. lopez..... Se necesitán medicamentos en méxico... Atención jonathanrockoff so that they can raise the price? Ha ha ha. Lower prices. Ha ha ha. Methinks I've heard that before. Ha ha ha.
Source: WSJ - 🏆 98. / 63 Read more »
Pfizer Nears Deal to Combine off-Patent Drug Business With MylanPfizer is in talks to merge its off-patent drugs business with generic drugmaker Mylan, in a deal that would create a giant global seller of lower-priced medicines. Sr. lopez atención sr. lopez..... Se necesitán medicamentos en méxico... Atención jonathanrockoff so that they can raise the price? Ha ha ha. Lower prices. Ha ha ha. Methinks I've heard that before. Ha ha ha.
Source: WSJ - 🏆 98. / 63 Read more »
Pfizer in talks to merge off-patent drugs business with MylanPfizer Inc is in talks to merge its off-patent drugs business with Mylan NV in a... Further consolidation that will result in increased drug prices. Republicans will say this is free market principals. Americans will blame Democrats either way.
Source: Reuters - 🏆 2. / 97 Read more »